LTFS
NBSE

Ladenburg Thalmann Financial Services’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Ladenburg Thalmann Financial Services’s Portfolio NBSE Stock Details NBSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$3K Hold
23
– – ﹤0.01% 4998
2019
Q3 		$2K Hold
23
– – ﹤0.01% 5024
2019
Q2 		$2K Buy
+23
New +$1.3K ﹤0.01% 5020
2016
Q3 		– Sell
-1
Closed -$1K – 4895
2016
Q2 		$1K Hold
1
– – ﹤0.01% 4632
2016
Q1 		$1K Buy
+1
New +$1.43K ﹤0.01% 4578

Other funds holding NBSE

GC
Greenlight Capital New York $2.05B AUM 78.75% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
EI
EAM Investors Solana Beach, California $866M AUM 377.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Ladenburg Thalmann Financial Services's NBSE Position: Q4 2019 in Review

Ladenburg Thalmann Financial Services held its NeuBase Therapeutics, Inc. Common Stock (NBSE) position steady in Q4 2019 at 23 shares worth $3K. The position accounts for ﹤0.01% of the portfolio, ranked #4998.

Ladenburg Thalmann Financial Services first reported a position in NBSE in Q1 2016 and has held it in 5 quarters since. 22 funds tracked by Wall St. Rank hold NBSE as of Q4 2019.

  • Ladenburg Thalmann Financial Services held 23 shares of NeuBase Therapeutics, Inc. Common Stock worth $3K as of Q4 2019.
  • Ladenburg Thalmann Financial Services left its NeuBase Therapeutics, Inc. Common Stock share count unchanged in Q4 2019.
  • NeuBase Therapeutics, Inc. Common Stock made up ﹤0.01% of Ladenburg Thalmann Financial Services's portfolio in Q4 2019, its #4998 holding.
  • Ladenburg Thalmann Financial Services first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2016 and has held it in 5 quarters since.
  • 22 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q4 2019.

Based on Ladenburg Thalmann Financial Services's 13F filing for Q4 2019, filed 14 Feb 2020.